US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.
As of the time of writing, the stock has risen more than 9%, reaching $9.398.
On Friday, the stock price of Teladoc Health (TDOC.US) rose, up over 9% to $9.398 as of the time of publication. Several Wall Street major banks updated their ratings on Teladoc Health, with price targets ranging from $9 to $12. Among them, Bank of America Securities analyst Allen Lutz maintained a hold rating and raised the target price from $8.5 to $9.
Related Articles
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
US Stock Market Move | Beyond Meat (BYND.US) fell more than 6.6%, with expected Q3 revenue of $70 million.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
US Stock Market Move | Beyond Meat (BYND.US) fell more than 6.6%, with expected Q3 revenue of $70 million.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
